CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice
Julia Weber(German Cancer Research Center), Roland Rad(ING Direct), Rickmer Braren(TUM Klinikum), Fengtang Yang(Shandong University of Technology), Ursula Ehmer(TUM Klinikum), Pentao Liu(Hong Kong Science and Technology Parks Corporation), Thomas Engleitner(Technical University of Munich), Mathias Heikenwälder(University of Tübingen), Irina Heid(TUM Klinikum), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Roman Maresch(Technical University of Munich), Ulf Geumann(German Cancer Research Center), Sebastian Lange(TUM Klinikum), Rupert Öllinger(Technical University of Munich), Kristian Unger(Helmholtz Zentrum München), Detian Yuan(German Cancer Research Center), Beiyuan Fu(Wellcome Sanger Institute), Jorge de la Rosa(University of Cambridge), Ignacio Varela(Wellcome Sanger Institute), Maxim Barenboim(German Cancer Research Center), Angela Segler(TUM Klinikum), Iréne Esposito(Heinrich Heine University Düsseldorf), Allan Bradley(Granta Design (United Kingdom)), Nina Groß(Technical University of Munich), Günter Schneider(TUM Klinikum), Alexander Strong(Wellcome Sanger Institute), Dieter Saur(German Cancer Research Center), Roland M. Schmid(Tumkur University), Sebastian Mueller(TUM Klinikum), Katja Steiger(Technical University of Munich), Mathias Friedrich, Juan Cadiñanos(Universidad de Oviedo)
Cited by 195
Related Papers
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k